Table 1 Associations between sample characteristics and use of varenicline or NRT Rx
Variable | Varenicline | NRT Rx | P |
|---|---|---|---|
(N = 118) | (N = 152) | ||
Non-smoker at follow-up | 39.8 (47) | 19.7 (30) | <0.001 |
Age at baseline, mean (SD) | 46.0 (12.2) | 51.7 (13.8) | <0.001 |
Female sex | 57.6 (68) | 56.6 (86) | 0.863 |
Social grade | |||
AB | 2.5 (3) | 10.5 (16) | <0.001 |
C1 | 29.7 (35) | 17.8 (27) | |
C2 | 23.7 (28) | 11.8 (18) | |
D | 22.0 (26) | 18.4 (28) | |
E | 22.0 (26) | 41.4 (63) | |
Number of quit attempts prior to the most recent one at follow-up | |||
0 | 83.1 (98) | 73.0 (111) | 0.147 |
1 | 12.7 (15) | 19.7 (30) | |
2 | 4.2 (5) | 7.2 (11) | |
Time since last quit attempt started at follow-up | |||
<=1 week | 7.6 (9) | 9.2 (14) | 0.097 |
1–4 weeks | 8.5 (10) | 13.8 (21) | |
4–8 weeks | 22.0 (26) | 18.4 (28) | |
8–12 weeks | 22.0 (26) | 31.6 (48) | |
12–26 weeks | 39.8 (47) | 27.0 (41) | |
Stopped abruptly during last quit attempt at follow-up (versus cut down first) | 35.6 (42) | 52.0 (79) | 0.007 |
Time spent with urges to smoke at baseline, mean (SD) | 3.6 (1.3) | 3.2 (1.1) | 0.006 |
Strength of urges to smoke at baseline, mean (SD) | 2.4 (1.1) | 2.3 (1.0) | 0.481 |